twoXAR Pharmaceuticals SVP Nonclinical R&D & Chemistry Anjali Pandey moderates a panel including twoXAR CEO Andrew Radin, along with representatives from Recursion Pharma, ATOM Consortium, and NuMedii.
twoXAR Pharmaceuticals CEO Andrew Radin presents on the company's capabilities in discovering first-in-class small molecules for oncology and more using AI.
twoXAR Pharmaceuticals VP Discovery, Aaron Daugherty, joins DrugBank CEO Michael Wilson in an online fireside chat on using DrugBank data sources for drug discovery.